| scholarly article | Q13442814 |
| P50 | author | Margaret von Mehren | Q66809438 |
| Andrew K Godwin | Q89896596 | ||
| P2093 | author name string | David Riddell | |
| Kathy Q Cai | |||
| Joseph R Testa | |||
| Jianming Pei | |||
| Lori Rink | |||
| Martin G Belinsky | |||
| Burton L Eisenberg | |||
| Lisa A Vanderveer | |||
| Erin Merkel | |||
| Chi Tarn | |||
| Yuliya V Skorobogatko | |||
| P2860 | cites work | Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status | Q61781154 |
| DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance | Q74088062 | ||
| Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors | Q77311208 | ||
| An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications | Q79568269 | ||
| Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas | Q80283497 | ||
| Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor | Q80298660 | ||
| Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients | Q80971360 | ||
| Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors | Q81381492 | ||
| Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study | Q81383348 | ||
| KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size | Q27824783 | ||
| Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor | Q27824804 | ||
| Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors | Q28118852 | ||
| Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis | Q28272917 | ||
| Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors | Q29618610 | ||
| Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population | Q33654872 | ||
| Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors | Q33988695 | ||
| PDGFRA activating mutations in gastrointestinal stromal tumors. | Q34169772 | ||
| Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group | Q34546186 | ||
| Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up | Q34553656 | ||
| Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors | Q34576648 | ||
| Diagnosis of gastrointestinal stromal tumors: a consensus approach | Q34697685 | ||
| Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal | Q34747216 | ||
| Improved detection of KIT exon 11 duplications in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors | Q35789573 | ||
| Biology of gastrointestinal stromal tumors. | Q35886298 | ||
| Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs). | Q36082596 | ||
| Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature | Q36101673 | ||
| Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature | Q36256478 | ||
| Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria | Q36609605 | ||
| Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors | Q36751533 | ||
| p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome | Q36897784 | ||
| Molecular pathobiology of gastrointestinal stromal sarcomas. | Q37014848 | ||
| Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. | Q37023177 | ||
| Therapeutic strategies for targeting BRAF in human cancer | Q37161265 | ||
| Molecular characterization of pediatric gastrointestinal stromal tumors. | Q37247100 | ||
| The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors | Q37279733 | ||
| Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study | Q43797374 | ||
| KIT activation is a ubiquitous feature of gastrointestinal stromal tumors | Q43806543 | ||
| Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway | Q45023853 | ||
| Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling | Q46493673 | ||
| Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications | Q53620654 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 886-896 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
| P1476 | title | High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors | |
| P478 | volume | 48 |
| Q43465485 | A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number |
| Q36793267 | ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression |
| Q38119931 | An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST). |
| Q39148688 | Bench to Bedside and Back Again: Personalizing Treatment for Patients with GIST |
| Q36125976 | Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor |
| Q35562510 | Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors. |
| Q37001194 | Drug Repurposing for Gastrointestinal Stromal Tumor |
| Q34289180 | Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor |
| Q39500990 | Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction |
| Q35017113 | GSTT1 copy number gain and ZNF overexpression are predictors of poor response to imatinib in gastrointestinal stromal tumors |
| Q82948349 | Gastrointestinal stromal tumors |
| Q38090985 | Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria |
| Q34510184 | Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kit. |
| Q38105496 | Novel Pathways and Molecular Targets for the Treatment of Sarcoma |
| Q36587153 | Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors |
| Q50098425 | Pediatric GIST presenting as anemia |
| Q34171517 | Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches |
| Q26829970 | Primary gastrointestinal stromal tumors: Current advances in diagnostic biomarkers, prognostic factors and management of its duodenal location |
| Q35837219 | Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case. |
| Q36850606 | Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors |
| Q34055567 | Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor |
| Q39817075 | The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs). |
| Q37716749 | Tumor-derived exosomes: A message delivery system for tumor progression. |
Search more.